UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
KALV holding history
KalVista Pharmaceuticals, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KALV overviewAll 13F holders of KALVFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −79,460−100.0% | Sold out | Holders |
| Q2 2025 | 79,460 | $898.3K | <0.1% | −90,232−53.2% | Reduced | Holders |
| Q1 2025 | 169,692 | $1.96M | <0.1% | −3,001−1.7% | Reduced | Holders |
| Q4 2024 | 172,693 | $1.46M | <0.1% | +37,141+27.4% | Added | Holders |
| Q3 2024 | 135,552 | $1.57M | <0.1% | +12,592+10.2% | Added | Holders |
| Q2 2024 | 122,960 | $1.45M | <0.1% | +40,960+50.0% | Added | Holders |
| Q1 2024 | 82,000 | $972.5K | <0.1% | +82,000 | New | Holders |